Utility of NT-proBNP for Identifying LV Failure in Patients with Acute Exacerbation of Chronic Bronchitis

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Wang, Qing Ping ^a,b   Cao, Xiao Zhi ^c   Wang, Xue Dong ^a   Gu, Juan ^a   Wen, Li Min ^b   Mao, Li Ming ^b   Shan, Ping Nan ^b   Tang, Ai Guo ^d  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Department of Clinical Laboratory   (China)

^c FUZHOU GENERAL HOSPITAL   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

AGED; ANALYZER; ARTICLE; CHRONIC BRONCHITIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FAILURE; HUMAN; KIDNEY FUNCTION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROGNOSIS; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; BRONCHITIS, CHRONIC; CALIBRATION; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; ROC CURVE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84872336432     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052553     Document Type: Article

References (40)

1. Balter M, Grossman RF, (1997) Management of chronic bronchitis and acute exacerbations of chronic bronchitis. Int J Antimicrob Agents 9: 83-93.
2. Balter MS, La Forge J, Low DE, Mandell L, Grossman RF, (2003) Canadian guidelines for the management of acute exacerbations of chronic bronchitis: executive summary. Can Respir J 10: 248-258.
3. Donner CF, (2006) Acute exacerbation of chronic bronchitis: need for an evidence-based approach. Pulm Pharmacol Ther 19 Suppl 1: 4-10.
4. Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJ, et al. (2000) Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 118: 1557-1565.
5. Sethi S, (2000) Infectious etiology of acute exacerbations of chronic bronchitis. Chest 117: 380S-385S.
6. Albertson TE, Louie S, Chan AL, (2010) The diagnosis and treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bronchitis. J Am Geriatr Soc 58: 570-579.
7. Hayes D Jr, Meyer KC, (2007) Acute exacerbations of chronic bronchitis in elderly patients: pathogenesis, diagnosis and management. Drugs Aging 24: 555-572.
8. Tsang KW, (2001) Solutions for difficult diagnostic cases of acute exacerbations of chronic bronchitis. Chemotherapy 47 Suppl 4: 28-38 discussion 53-24.
9. Goetze JP, Mogelvang R, Maage L, Scharling H, Schnohr P, et al. (2006) Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction. Eur Heart J 27: 3004-3010.
10. Epshteyn V, Morrison K, Krishnaswamy P, Kazanegra R, Clopton P, et al. (2003) Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care 26: 2081-2087.
11. Clerico A, Fontana M, Zyw L, Passino C, Emdin M, (2007) Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. Clin Chem 53: 813-822.
12. Sirithunyanont C, Leowattana W, Sukumalchantra Y, Chaisupamonkollarp S, Watanawaroon S, et al. (2003) Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases. J Med Assoc Thai 86 Suppl 1: S87-95.
13. Mogelvang R, Goetze JP, Schnohr P, Lange P, Sogaard P, et al. (2007) Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide. J Am Coll Cardiol 50: 1694-1701.
14. Krauser DG, Chen AA, Tung R, Anwaruddin S, Baggish AL, et al. (2006) Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. J Card Fail 12: 452-457.
15. Tung RH, Camargo CA Jr, Krauser D, Anwaruddin S, Baggish A, et al. (2006) Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease. Ann Emerg Med 48: 66-74.
16. Zaninotto M, Mion M, Altinier S, Pastorello M, Rocco S, et al. (2005) NT-proBNP in the differential diagnosis of acute dyspnea in the emergency department. Clin Biochem 38: 1041-1044.
17. McCullough PA, Hollander JE, Nowak RM, Storrow AB, Duc P, et al. (2003) Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med 10: 198-204.
18. Clerico A, Giannoni A, Vittorini S, Passino C, (2011) Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones. Am J Physiol Heart Circ Physiol 301: H12-20.
19. Morello A, Lloyd-Jones DM, Chae CU, van Kimmenade RR, Chen AC, et al. (2007) Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Am Heart J 153: 90-97.
20. Luchner A, Hengstenberg C, Lowel H, Riegger GA, Schunkert H, et al. (2005) Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 46: 118-123.
21. Gariani K, Delabays A, Perneger TV, Agoritsas T, (2011) Use of brain natriuretic peptide to detect previously unknown left ventricular dysfunction in patients with acute exacerbation of chronic obstructive pulmonary disease. Swiss Med Wkly 141: w13298.
22. Hunt PJ, Yandle TG, Nicholls MG, Richards AM, Espiner EA, (1995) The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun 214: 1175-1183.
23. Abroug F, Ouanes-Besbes L, Nciri N, Sellami N, Addad F, et al. (2006) Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am J Respir Crit Care Med 174: 990-996.
24. Wang QP, Gu JW, Zhan XH, Li H, Luo XH, (2009) Assessment of glomerular filtration rate by serum cystatin C in patients undergoing coronary artery bypass grafting. Ann Clin Biochem 46: 495-500.
25. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, et al. (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10: 933-989.
26. Shelton RJ, Clark AL, Goode K, Rigby AS, Cleland JG, (2006) The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Eur Heart J 27: 2353-2361.
27. Sykes A, Mallia P, Johnston SL, (2007) Diagnosis of pathogens in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4: 642-646.
28. Abroug F, Ouanes-Besbes L, (2008) Detection of acute heart failure in chronic obstructive pulmonary disease patients: role of B-type natriuretic peptide. Curr Opin Crit Care 14: 340-347.
29. Fabbri LM, Luppi F, Beghe B, Rabe KF, (2008) Complex chronic comorbidities of COPD. Eur Respir J 31: 204-212.
30. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, et al. (2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26: 1115-1140.
31. Januzzi JL Jr, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, et al. (2005) The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95: 948-954.
32. Bayes-Genis A, Santalo-Bel M, Zapico-Muniz E, Lopez L, Cotes C, et al. (2004) N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur J Heart Fail 6: 301-308.
33. Villacorta H, Duarte A, Duarte NM, Carrano A, Mesquita ET, et al. (2002) The role of B-type natriuretic peptide in the diagnosis of congestive heart failure in patients presenting to an emergency department with dyspnea. Arq Bras Cardiol 79: 569-568, 569-572, 564-568.
34. Lainchbury JG, Campbell E, Frampton CM, Yandle TG, Nicholls MG, et al. (2003) Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 42: 728-735.
35. Nagaya N, Nishikimi T, Uematsu M, Satoh T, Kyotani S, et al. (2000) Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 102: 865-870.
36. Vassaux C, Torre-Bouscoulet L, Zeineldine S, Cortopassi F, Paz-Diaz H, et al. (2008) Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J 32: 1275-1282.
37. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA, (2000) Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161: 1608-1613.
38. Inoue Y, Kawayama T, Iwanaga T, Aizawa H, (2009) High plasma brain natriuretic peptide levels in stable COPD without pulmonary hypertension or cor pulmonale. Intern Med 48: 503-512.
39. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, et al. (2004) Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation 109: 3176-3181.
40. Clerico A, Emdin M, (2004) Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 50: 33-50.